Member Info for EarlofAim

Long term holders view

I agree you should be excited it is indeed a fantastic opportunity as Adrian states no one else in the industry has anything as good as Optimal. once NCI validate it there is likely to be a bidding war to secure it for big Pharma. starting bids will be in the region of $100 mil

Let's stay with the ground breaking technology for Antibodies on optimal®

Listen From 4min 20 sec onwards

#optimal® Ground breaking platform, no equivalent out there for £2.5m Mcap

https://youtu.be/8LiCjaamoPc?si=oBoQgQO4YDQHrQNw

join the dots.......

40 bagger potential!!

Copl

Mast

fab next

look at the fab bb posts

Glad I kept quite as I wasn't sure if Buyers will come today

excited for the Rns

Davy50

this time I'm not saying 40 bagger

look whose saying it....

join the dots.......

40 bagger potential!!

https://spongeshare.com/2023/06/06/trade-idea-fusion-antibodies-40-bags-back-to-highs-and-reasons-why-it-just-could-do-that/

My lucky charm Davy50,

Sp will go up crazy this afternoon, watch Mr Davy50

most not aware of the company’s magnitude in antibodies

#fab agree i remember when #pyc 30 bagged in 3 days #fab will multibag at some point imo

many not aware of the company potential yet!!

Just one Rns and it could change the outlook of the company

Davy50

don't worry, graphite stocks just taking a breather, sellers bored maybe

Davy50

don't worry, graphite stocks just taking a

Listen From 4min 20 sec onwards

#optimal® Ground breaking platform, no equivalent out there for £2.5m Mcap

https://youtu.be/8LiCjaamoPc?si=oBoQgQO4YDQHrQNw

join the dots.......

40 bagger potential!!

https://spongeshare.com/2023/06/06/trade-idea-fusion-antibodies-40-bags-back-to-highs-and-reasons-why-it-just-could-do-that/

Davy50

don't worry, graphite stocks just taking a breather,

if you want 40 bagger in the long run look at FAB also

Listen From 4min 20 sec onwards

#optimal® Ground breaking platform, no equivalent out there for £2.5m Mcap

https://youtu.be/8LiCjaamoPc?si=oBoQgQO4YDQHrQNw

Youtu.be/8LiCjaamoPc?si…

listen From 4min 20 sec onwards

#optimal® Ground breaking platform, no equivalent out there for £2.5m Mcap

Ground breaking technology platform and the market is Sleep on this one

Zak mir said 16p,

some saying £100m for the company

some saying 40 baggers from current position

Why copl can suddenly suspend?

senior bondholders have the answer

Board denies any suggestion that it preferred the interests of Anavio over COPL's shareholders. Having taken legal advice in relation to its duties, the Board specifically considered the interests of various stakeholders, including COPL's shareholders. Had the Board taken steps to wind down COPL, as some shareholders suggest, it was the Board's business judgment that COPL shareholders would have almost certainly been entirely wiped out. In considering various options, the Board concluded that the value of COPL's assets were insufficient to cover the claims of secured and unsecured creditors which today stand in excess of $135 million as compared with approximately $1 million of cash on hand on a group wide basis (the majority of such liquidity being at COPL's US subsidiary which is subject directly to the security interests of the senior lender). In addition to the $135 million of secured obligations which take priority over equity an orderly formal restructuring proceeding would require a super priority loan of approximately $10 million, putting equity investors of COPL even further "out of the money". As such, the steps taken by the Board (including the recent hiring of an independent engineering consulting firm) were designed to give COPL an opportunity to become more viable over time and to provide shareholders with a potential opportunity to realize some value (over no value in the wind down scenario).

The truth is COPL assets according to Last week's rns not enough to cover £135m debts.

more likely Senior Bondholders will take this private

anyone else thinks different

Fantastic update on LinkedIn

https://www.linkedin.com/posts/richardbuick_antibodyeng-activity-7143628569481543681-gLxX?utm_source=share&utm_medium=member_android

No placing worries for at least 5 months or so

One report only that all is on track and no raise necessary .

Post from LinkedIn.....

This is a great reminder that we should anticipate some good news soon.

Richard Buicks post

Following a very busy week at Antibody Engineering and Therapeutics in San Diego, it's time to look back on some of the highlights. It was very interesting to learn from Moderna that affinity maturation of antibodies can continue for 5-6 months post vaccination. And on the theme of affinity maturation I found Karl Dane Wittrup's slides on the necessary affinities for different modalities particularly useful, as it is often the case that the highest affinity does not equate to the most efficacious drug.

A couple of drug candidates that stood out among the therapeutics were Genmab's and BioNTech SE's anti-CD27 HexaBody and IcanoMAB GmbH's agonistic anti-CD40 antibody.

We progressed discussions on existing and additional projects with key clients during the meeting and have formed new relationships that we will be following up with in the New Year. #AntibodyEng is an excellent conference to conclude 2023 and gives impetus to start 2024 with renewed excitement.

Happy Holidays and have a very prosperous 2024.